Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Cholagogues and Choleretics"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 229
Tytuł:
Pharmacotherapy for primary biliary cholangitis: an assessment of medication candidacy and rates of treatment.
Autorzy:
MacDonald N; Department of Medicine, Thomas Jefferson University Hospital, 33 S 9 TH St, Suite 220, 19107, Philadelphia, PA, USA. .
Loh R; Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, 132 South 10th Street, Suite 480, 19107, Philadelphia, PA, USA.
Fenkel JM; Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, 132 South 10th Street, Suite 480, 19107, Philadelphia, PA, USA.
Sass DA; Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, 132 South 10th Street, Suite 480, 19107, Philadelphia, PA, USA.
Halegoua-DeMarzio D; Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, 132 South 10th Street, Suite 480, 19107, Philadelphia, PA, USA.
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2024 Jan 04; Vol. 24 (1), pp. 18. Date of Electronic Publication: 2024 Jan 04.
Typ publikacji:
Journal Article
MeSH Terms:
Cholangitis*/drug therapy
Liver Cirrhosis, Biliary*/drug therapy
Humans ; Cholagogues and Choleretics/therapeutic use ; Ursodeoxycholic Acid/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
High neutrophil-lymphocyte ratio indicates a worse response to ursodeoxycholic acid in primary biliary cholangitis: a retrospective cohort study.
Autorzy:
Zhu H; Department of Gastroenterology, Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Zheng M; Department of Gastroenterology, Second Affiliated Hospital of Kunming Medical University, Kunming, China.
He H; Department of Gastroenterology, Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Lei H; School of Public Health Kunming Medical University, Kunming, China.
Tai W; Clinical Lab, Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Yang J; Department of Gastroenterology, Second Affiliated Hospital of Kunming Medical University, Kunming, China. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2023 Nov 17; Vol. 23 (1), pp. 400. Date of Electronic Publication: 2023 Nov 17.
Typ publikacji:
Journal Article
MeSH Terms:
Ursodeoxycholic Acid*/therapeutic use
Ursodeoxycholic Acid*/adverse effects
Liver Cirrhosis, Biliary*/drug therapy
Liver Cirrhosis, Biliary*/complications
Humans ; Retrospective Studies ; Cholagogues and Choleretics/therapeutic use ; Neutrophils ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study.
Autorzy:
Chang JI; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.; Department of Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea.
Kim JH; Division of Gastroenterology, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.
Sinn DH; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Cho JY; Department of Internal Medicine, Chosun University College of Medicine, Gwangju, Korea.
Kim KM; Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.
Oh JH; Department of Medicine, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Korea.
Park Y; Department of Internal Medicine, College of Medicine, Kyung Hee University, Seoul, Korea.
Sohn W; Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Goh MJ; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kang W; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Gwak GY; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Paik YH; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Choi MS; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Lee JH; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Koh KC; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Paik SW; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Gut and liver [Gut Liver] 2023 Jul 15; Vol. 17 (4), pp. 620-628. Date of Electronic Publication: 2023 Mar 31.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Ursodeoxycholic Acid*/therapeutic use
Liver Cirrhosis, Biliary*/drug therapy
Liver Cirrhosis, Biliary*/pathology
Humans ; Cholagogues and Choleretics/therapeutic use ; Cohort Studies ; Republic of Korea ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Efficacy of ursodeoxycholic acid for primary biliary cholangitis: Experience from a tertiary care centre in Saudi Arabia.
Autorzy:
AlWabel AH; Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Peedikayil M; Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
AlNasser S; Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
AlHusaini K; Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
AlHekail O; Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Alqahtani SA; Department of Medicine, King Faisal Specialist Hospital & Research Centre; Organ Transplant Center, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
AlTraif IH; Hepatology Division, Department of Hepatobiliary Sciences and Organ Transplant Center, King Abdulaziz Medical City; King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
AlAshgar H; Department of Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia.
Pokaż więcej
Źródło:
Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association [Saudi J Gastroenterol] 2023 Mar-Apr; Vol. 29 (2), pp. 135-140.
Typ publikacji:
Journal Article
MeSH Terms:
Ursodeoxycholic Acid*/therapeutic use
Liver Cirrhosis, Biliary*/complications
Liver Cirrhosis, Biliary*/drug therapy
Liver Cirrhosis, Biliary*/diagnosis
Male ; Humans ; Female ; Middle Aged ; Cholagogues and Choleretics/therapeutic use ; Tertiary Care Centers ; Saudi Arabia/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid.
Autorzy:
de Veer RC; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Harms MH; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Corpechot C; Reference Center for Inflammatory Biliary Diseases and Autoimmune Hepatitis, European Reference Network on Hepatological Diseases (ERN Rare-Liver), Saint-Antoine Hospital, Assistance Publique - Hôpitaux de Paris; Inserm UMR_S938, Saint-Antoine Research Center, Sorbonne University, Paris, France.
Thorburn D; The Sheila Sherlock Liver Centre, and UCL Institute of Liver and Digestive Health, The Royal Free Hospital, London, UK.
Invernizzi P; Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Janssen HLA; Toronto Centre for Liver disease, Toronto General Hospital, University Health Network, Toronto, Canada.
Battezzati PM; Department of Health Sciences, Università degli Studi di Milano, Milan, Italy.
Nevens F; Department of Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Lindor KD; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.; Arizona State University, College of Health Solutions, Phoenix, Arizona, USA.
Floreani A; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.; Scientific Institute for Research, Hospitalization and Healthcare, Negrar, Verona, Italy.
Ponsioen CY; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centres, location Academic Medical Center, Amsterdam, The Netherlands.
Mayo MJ; Digestive and Liver diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
Parés A; Liver Unit, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Spain.
Mason AL; Division of Gastroenterology and Hepatology, University of Alberta, Edmonton, Alberta, Canada.
Kowdley KV; Liver Care Network and Organ Care Research, Swedish Medical Center, Seattle, WA, USA.
Trivedi PJ; Birmingham NIHR Biomedical Research Centre, and Centre for Liver Research, University of Birmingham, Birmingham, UK.
Hirschfield GM; Toronto Centre for Liver disease, Toronto General Hospital, University Health Network, Toronto, Canada.; Birmingham NIHR Biomedical Research Centre, and Centre for Liver Research, University of Birmingham, Birmingham, UK.
Bruns T; Department of Internal Medicine IV, Jena University Hospital, Friedrich Schiller University, Jena, Germany.; Department of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Dalekos GN; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), General University Hospital of Larissa, Larissa, Greece.
Gatselis NK; Department of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Larissa, Greece.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), General University Hospital of Larissa, Larissa, Greece.
Verhelst X; Department of Gastroenterology and Hepatology, Ghent University Hospital, Belgium.
Lammers WJ; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Hansen BE; Toronto Centre for Liver disease, Toronto General Hospital, University Health Network, Toronto, Canada.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada.
van Buuren HR; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
van der Meer AJ; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Pokaż więcej
Corporate Authors:
Global PBC Study Group
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Nov; Vol. 56 (9), pp. 1408-1418. Date of Electronic Publication: 2022 Sep 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Liver Cirrhosis, Biliary*/diagnosis
Liver Cirrhosis, Biliary*/drug therapy
Liver Cirrhosis, Biliary*/surgery
Liver Transplantation*
Alkaline Phosphatase ; Cholagogues and Choleretics/therapeutic use ; Humans ; Ursodeoxycholic Acid/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Machine learning in primary biliary cholangitis: A novel approach for risk stratification.
Autorzy:
Gerussi A; Division of Gastroenterology, Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
Verda D; Rulex Inc, Newton, Massachusetts, USA.
Bernasconi DP; Bicocca Bioinformatics Biostatistics and Bioimaging Centre - B4, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Carbone M; Division of Gastroenterology, Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
Komori A; Clinical Research Center, National Hospital Organization (NHO) Nagasaki Medical Center, Nagasaki, Japan.
Abe M; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan.
Inao M; Department of Gastroenterology and Hepatology, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
Namisaki T; Department of Gastroenterology, Nara Medical University, Nara, Japan.
Mochida S; Department of Gastroenterology and Hepatology, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
Yoshiji H; Department of Gastroenterology, Nara Medical University, Nara, Japan.
Hirschfield G; Toronto Centre for Liver Disease, Toronto Western & General Hospital, University Health Network, Toronto, Ontario, Canada.; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
Lindor K; Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, Arizona, United States.; Arizona State University, Phoenix, Arizona, United States.
Pares A; Liver Unit, Hospital Clínic, CIBERehd, IDIBAPS, University of Barcelona, Barcelona, Spain.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hospital Clinic de Barcelona, Barcelona, Spain.
Corpechot C; Centre de Référence des Maladies Inflammatoires des Voies Biliaires et des Hépatites auto-immunes, Hôpital Saint- Antoine, APHP-Sorbonne Université, Paris, France.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Hôpital Saint-Antoine, Paris, France.
Cazzagon N; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), Azienda Ospedale - Università Padova, Padova, Italy.
Floreani A; Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.; Scientific Institute for Research, Hospitalization and Healthcare, Verona, Italy.
Marzioni M; Division of Gastroenterology and Hepatology, Ospedali Riuniti University Hospital, Ancona, Italy.
Alvaro D; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Vespasiani-Gentilucci U; Clinical Medicine and Hepatology Unit, Campus Bio-Medico University of Rome, Rome, Italy.
Cristoferi L; Division of Gastroenterology, Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.; Bicocca Bioinformatics Biostatistics and Bioimaging Centre - B4, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Valsecchi MG; Bicocca Bioinformatics Biostatistics and Bioimaging Centre - B4, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Muselli M; Rulex Inc, Newton, Massachusetts, USA.; Institute of Electronics, Computer and Telecommunication Engineering, National Research Council of Italy, Genova, Italy.
Hansen BE; Clinical Research Center, National Hospital Organization (NHO) Nagasaki Medical Center, Nagasaki, Japan.; Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime, Japan.
Tanaka A; Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Invernizzi P; Division of Gastroenterology, Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2022 Mar; Vol. 42 (3), pp. 615-627. Date of Electronic Publication: 2022 Jan 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cholangitis*/complications
Liver Cirrhosis, Biliary*/drug therapy
Cholagogues and Choleretics/therapeutic use ; Humans ; Machine Learning ; Prognosis ; Risk Assessment ; Ursodeoxycholic Acid/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Acquired palmoplantar keratoderma associated with primary biliary cholangitis: Complete and persistent resolution after ursodeoxycholic acid treatment.
Autorzy:
March-Rodriguez A; Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain.
Marcantonio O; Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain.
Olmos-Alpiste F; Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain.
Pujol RM; Department of Dermatology, Hospital del Mar-Parc de Salut Mar, Barcelona, Spain.
Pokaż więcej
Źródło:
The Australasian journal of dermatology [Australas J Dermatol] 2022 Feb; Vol. 63 (1), pp. e49-e51. Date of Electronic Publication: 2021 Dec 14.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Cholagogues and Choleretics/*therapeutic use
Keratoderma, Palmoplantar/*drug therapy
Liver Cirrhosis, Biliary/*drug therapy
Ursodeoxycholic Acid/*therapeutic use
Female ; Humans ; Keratoderma, Palmoplantar/etiology ; Liver Cirrhosis, Biliary/complications ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Alterations in gut microbiota and elevated serum bilirubin in primary biliary cholangitis patients treated with ursodeoxycholic acid.
Autorzy:
Han W; Department of Liver Disease Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Huang C; Second Department of liver disease center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Zhang Q; Department of Liver Disease Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Tao S; Department of Liver Disease Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Hu X; Department of Liver Disease Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Xu J; Department of Liver Disease Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Jiang R; Department of Liver Disease Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Xu B; Second Department of liver disease center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Liu Y; Second Department of liver disease center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Hou J; Department of Liver Disease Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Pokaż więcej
Źródło:
European journal of clinical investigation [Eur J Clin Invest] 2022 Feb; Vol. 52 (2), pp. e13714. Date of Electronic Publication: 2021 Dec 09.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Gastrointestinal Microbiome*
Bilirubin/*blood
Cholagogues and Choleretics/*therapeutic use
Liver Cirrhosis, Biliary/*blood
Liver Cirrhosis, Biliary/*drug therapy
Liver Cirrhosis, Biliary/*microbiology
Ursodeoxycholic Acid/*therapeutic use
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Deoxycholic Acid Modulates Cell-Junction Gene Expression and Increases Intestinal Barrier Dysfunction.
Autorzy:
Zeng H; United States Department of Agriculture, Agricultural Research Service, Grand Forks Human Nutrition Research Center, Grand Forks, ND 58203, USA.
Safratowich BD; United States Department of Agriculture, Agricultural Research Service, Grand Forks Human Nutrition Research Center, Grand Forks, ND 58203, USA.
Cheng WH; Department of Food Science, Nutrition and Health Promotion, Mississippi State University, Starkville, MS 39762, USA.
Larson KJ; United States Department of Agriculture, Agricultural Research Service, Grand Forks Human Nutrition Research Center, Grand Forks, ND 58203, USA.
Briske-Anderson M; United States Department of Agriculture, Agricultural Research Service, Grand Forks Human Nutrition Research Center, Grand Forks, ND 58203, USA.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Jan 22; Vol. 27 (3). Date of Electronic Publication: 2022 Jan 22.
Typ publikacji:
Journal Article
MeSH Terms:
Cholagogues and Choleretics/*pharmacology
Colon/*metabolism
Deoxycholic Acid/*pharmacology
Gene Expression Regulation/*drug effects
Intercellular Junctions/*metabolism
Intestinal Mucosa/*metabolism
Caco-2 Cells ; Cell Proliferation ; Colon/drug effects ; Humans ; Intercellular Junctions/drug effects ; Intercellular Junctions/genetics ; Intestinal Mucosa/drug effects ; Permeability
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bezafibrate therapy in primary biliary cholangitis refractory to ursodeoxycholic acid: a longitudinal study of paired liver biopsies at 5 years of follow up.
Autorzy:
Sorda JA; Department of Gastroenterology and Hepatology, University Hospital 'José de San Martín', Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina.
González Ballerga E; Department of Gastroenterology and Hepatology, University Hospital 'José de San Martín', Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina.
Barreyro FJ; Biotechnology Institute of Misiones (INBIOMIS), National University of Misiones, National Scientific and Technical Research Council (CONICET), Posadas, Argentina.
Avagnina A; Department of Pathology, University Hospital 'José de San Martín', Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina.
Carballo P; Department of Pathology, University Hospital 'José de San Martín', Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina.
Paes de Lima A; Department of Pathology, University Hospital 'José de San Martín', Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina.
Daruich J; Department of Gastroenterology and Hepatology, University Hospital 'José de San Martín', Faculty of Medicine, University of Buenos Aires, Buenos Aires, Argentina.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Nov; Vol. 54 (9), pp. 1202-1212. Date of Electronic Publication: 2021 Sep 29.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Cirrhosis, Biliary*/drug therapy
Ursodeoxycholic Acid*/therapeutic use
Bezafibrate/therapeutic use ; Biopsy ; Cholagogues and Choleretics/therapeutic use ; Drug Therapy, Combination ; Follow-Up Studies ; Humans ; Longitudinal Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tauroursodeoxycholic Acid Decreases Keloid Formation by Reducing Endoplasmic Reticulum Stress as Implicated in the Pathogenesis of Keloid.
Autorzy:
Kim S; Department of Plastic and Reconstructive Surgery, College of Medicine, Chungnam National University, Daejeon 35015, Korea.
Lee SE; Research Institute for Medicinal Sciences, College of Medicine, Chungnam National University, Daejeon 35015, Korea.
Yi S; Research Institute for Medicinal Sciences, College of Medicine, Chungnam National University, Daejeon 35015, Korea.
Jun S; Center for Research Equipment, Korea Basic Science Institute, Daejeon 34133, Korea.; Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.
Yi YS; Center for Research Equipment, Korea Basic Science Institute, Daejeon 34133, Korea.
Nagar H; Department of Physiology, College of Medicine, Chungnam National University, Daejeon 35015, Korea.
Kim CS; Department of Physiology, College of Medicine, Chungnam National University, Daejeon 35015, Korea.
Shin C; Department of Plastic and Reconstructive Surgery, College of Medicine, Chungnam National University, Daejeon 35015, Korea.
Yeo MK; Department of Pathology, College of Medicine, Chungnam National University, Daejeon 35015, Korea.
Kang YE; Research Institute for Medicinal Sciences, College of Medicine, Chungnam National University, Daejeon 35015, Korea.; Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Chungnam National University, Daejeon 35015, Korea.
Oh SH; Department of Plastic and Reconstructive Surgery, College of Medicine, Chungnam National University, Daejeon 35015, Korea.; Brain Research Institute, College of Medicine, Chungnam National University, Daejeon 35015, Korea.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Oct 05; Vol. 22 (19). Date of Electronic Publication: 2021 Oct 05.
Typ publikacji:
Journal Article
MeSH Terms:
Cholagogues and Choleretics/*pharmacology
Endoplasmic Reticulum Stress/*drug effects
Keloid/*prevention & control
Taurochenodeoxycholic Acid/*pharmacology
Adult ; Animals ; Apoptosis ; Case-Control Studies ; Female ; Humans ; Keloid/etiology ; Keloid/metabolism ; Keloid/pathology ; Male ; Rabbits ; Signal Transduction
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Safety of fibrates in cholestatic liver diseases.
Autorzy:
Carrion AF; Division of Gastroenterology and Hepatology, University of Miami, Miami, FL, USA.
Lindor KD; Division of Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, USA.; Office of University Provost, Arizona State University, Phoenix, AZ, USA.
Levy C; Division of Gastroenterology and Hepatology, University of Miami, Miami, FL, USA.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2021 Jun; Vol. 41 (6), pp. 1335-1343. Date of Electronic Publication: 2021 Mar 18.
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
Cholagogues and Choleretics*/adverse effects
Liver Cirrhosis, Biliary*/drug therapy
Bezafibrate/adverse effects ; Fibric Acids/adverse effects ; Humans ; Ursodeoxycholic Acid/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pharmaceutical suspensions of ursodeoxycholic acid for pediatric patients: in vitro and in vivo studies.
Autorzy:
Boscolo O; Departamento de Tecnología Farmacéutica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Salvo L; Departamento de Tecnología Farmacéutica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Dobrecky C; Departamento de Tecnología Farmacéutica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Fissore EN; Departamento de Industrias, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, ITAPROQ-UBA-CONICET, Buenos Aires, Argentina.; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Buontempo F; Departamento de Tecnología Farmacéutica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.; Servicio de Farmacia. Hospital de Pediatría Prof. Dr Juan Patricio. Garrahan, Buenos Aires, Argentina.
Tripodi V; Departamento de Tecnología Farmacéutica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Lucangioli SE; Departamento de Tecnología Farmacéutica, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
Pokaż więcej
Źródło:
Pharmaceutical development and technology [Pharm Dev Technol] 2021 Jun; Vol. 26 (5), pp. 599-609. Date of Electronic Publication: 2021 Apr 06.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Cholagogues and Choleretics/*administration & dosage
Excipients/*chemistry
Ursodeoxycholic Acid/*administration & dosage
Administration, Oral ; Animals ; Biological Availability ; Chemistry, Pharmaceutical ; Cholagogues and Choleretics/chemistry ; Cholagogues and Choleretics/pharmacokinetics ; Drug Stability ; Drug Storage ; Humidity ; Male ; Rats ; Rats, Sprague-Dawley ; Rheology ; Solubility ; Suspensions ; Temperature ; Ursodeoxycholic Acid/chemistry ; Ursodeoxycholic Acid/pharmacokinetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis.
Autorzy:
Soret PA; Paris, France.
Lam L; Paris, France.
Carrat F; Paris, France.
Smets L; Leuven, Belgium.
Berg T; Leipzig, Germany.
Carbone M; Monza, Italy.
Invernizzi P; Monza, Italy.
Leroy V; Grenoble, France.
Trivedi P; Birmingham, UK.
Cazzagon N; Padova, Italy.
Weiler-Normann C; Hamburg, Germany.
Alric L; Toulouse, France.
Rosa-Hezode I; Créteil, France.
Heurgué A; Reims, France.
Cervoni JP; Besançon, France.
Dumortier J; Lyon, France.
Potier P; Orléans, France.
Roux O; Clichy, France.
Silvain C; Poitiers, France.
Bureau C; Toulouse, France.
Anty R; Nice, France.
Larrey D; Montpellier, France.
Levy C; Miami, USA.
Pares A; Barcelona, Spain.
Schramm C; Hamburg, Germany.
Nevens F; Leuven, Belgium.
Chazouillères O; Paris, France.
Corpechot C; Paris, France.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 May; Vol. 53 (10), pp. 1138-1146. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Cirrhosis, Biliary*/drug therapy
Chenodeoxycholic Acid/analogs & derivatives ; Cholagogues and Choleretics/therapeutic use ; Fibric Acids/therapeutic use ; Humans ; Retrospective Studies ; Ursodeoxycholic Acid/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Evaluation of acute and subacute toxicity of sodium taurodeoxycholate in rats.
Autorzy:
Choi HJ; Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
Yun JW; Department of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea.
Kim YH; Wide River Institute of Immunology, Department of Microbiology and Immunology, Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kwon E; Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
Hyon MK; Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
Kim JY; Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.
Che JH; Biomedical Center for Animal Resource and Development, Seoul National University College of Medicine, Seoul, Republic of Korea.
Ho Kim W; Department of Pathology, Seoul National University College of Medicine, Seoul, Republic of Korea.
Seong SY; Wide River Institute of Immunology, Department of Microbiology and Immunology, Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
Kang BC; Graduate School of Translational Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Experimental Animal Research, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea.; Biomedical Center for Animal Resource and Development, Seoul National University College of Medicine, Seoul, Republic of Korea.; Designed Animal and Transplantation Research Institute, Institute of GreenBio Science Technology, Seoul National University, Pyeongchang-gun, Gangwon-do, Republic of Korea.
Pokaż więcej
Źródło:
Drug and chemical toxicology [Drug Chem Toxicol] 2021 May; Vol. 44 (3), pp. 268-276. Date of Electronic Publication: 2019 Jun 19.
Typ publikacji:
Journal Article
MeSH Terms:
Cholagogues and Choleretics/*toxicity
Taurodeoxycholic Acid/*toxicity
Animals ; Chemical and Drug Induced Liver Injury/etiology ; Cholagogues and Choleretics/administration & dosage ; Dose-Response Relationship, Drug ; Edema/chemically induced ; Female ; Infusions, Intravenous ; Lethal Dose 50 ; Male ; Rats ; Rats, Sprague-Dawley ; Taurodeoxycholic Acid/administration & dosage ; Toxicity Tests, Acute ; Toxicity Tests, Subacute
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Role of mitochondria in the differential action of sodium deoxycholate and ursodeoxycholic acid on rat duodenum.
Autorzy:
Pérez A; Laboratorio 'Dr. Fernando Cañas', Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, INICSA (CONICET-Universidad Nacional de Córdoba), Pabellón Argentina, 2do. Piso, Ciudad Universitaria, 5000 Córdoba, Argentina.; Laboratorio 'Dr. Fernando Cañas', Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, INICSA (CONICET-Universidad Nacional de Córdoba), Pabellón Argentina, 2do. Piso, Ciudad Universitaria, 5000 Córdoba, Argentina.
Rivoira MA; Laboratorio 'Dr. Fernando Cañas', Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, INICSA (CONICET-Universidad Nacional de Córdoba), Pabellón Argentina, 2do. Piso, Ciudad Universitaria, 5000 Córdoba, Argentina.; Laboratorio 'Dr. Fernando Cañas', Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, INICSA (CONICET-Universidad Nacional de Córdoba), Pabellón Argentina, 2do. Piso, Ciudad Universitaria, 5000 Córdoba, Argentina.
Rodríguez V; Laboratorio 'Dr. Fernando Cañas', Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, INICSA (CONICET-Universidad Nacional de Córdoba), Pabellón Argentina, 2do. Piso, Ciudad Universitaria, 5000 Córdoba, Argentina.; Laboratorio 'Dr. Fernando Cañas', Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, INICSA (CONICET-Universidad Nacional de Córdoba), Pabellón Argentina, 2do. Piso, Ciudad Universitaria, 5000 Córdoba, Argentina.
Marchionatti A; Laboratorio 'Dr. Fernando Cañas', Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, INICSA (CONICET-Universidad Nacional de Córdoba), Pabellón Argentina, 2do. Piso, Ciudad Universitaria, 5000 Córdoba, Argentina.; Laboratorio 'Dr. Fernando Cañas', Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, INICSA (CONICET-Universidad Nacional de Córdoba), Pabellón Argentina, 2do. Piso, Ciudad Universitaria, 5000 Córdoba, Argentina.
Tolosa de Talamoni N; Laboratorio 'Dr. Fernando Cañas', Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, INICSA (CONICET-Universidad Nacional de Córdoba), Pabellón Argentina, 2do. Piso, Ciudad Universitaria, 5000 Córdoba, Argentina.; Laboratorio 'Dr. Fernando Cañas', Cátedra de Bioquímica y Biología Molecular, Facultad de Ciencias Médicas, INICSA (CONICET-Universidad Nacional de Córdoba), Pabellón Argentina, 2do. Piso, Ciudad Universitaria, 5000 Córdoba, Argentina.
Pokaż więcej
Źródło:
Canadian journal of physiology and pharmacology [Can J Physiol Pharmacol] 2021 Mar; Vol. 99 (3), pp. 270-277. Date of Electronic Publication: 2020 Jul 20.
Typ publikacji:
Journal Article
MeSH Terms:
Cholagogues and Choleretics/*pharmacology
Deoxycholic Acid/*pharmacology
Duodenum/*drug effects
Mitochondria/*metabolism
Ursodeoxycholic Acid/*pharmacology
Animals ; Calcium/pharmacokinetics ; Cholagogues and Choleretics/pharmacokinetics ; Citric Acid Cycle/drug effects ; Deoxycholic Acid/pharmacokinetics ; Electron Transport ; Intestinal Absorption/drug effects ; Male ; Mitochondrial Proton-Translocating ATPases/metabolism ; Organelle Biogenesis ; Oxidative Phosphorylation/drug effects ; Oxidative Stress ; Rats ; Rats, Wistar ; Superoxide Dismutase/metabolism ; Ursodeoxycholic Acid/pharmacokinetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Effectiveness and safety of obeticholic acid in a Southern European multicentre cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid.
Autorzy:
Gomez E; Madrid, Spain.
Garcia Buey L; Madrid, Spain.
Molina E; Santiago, Spain.
Casado M; Almeria, Spain.
Conde I; Valencia, Spain.
Berenguer M; Valencia, Spain.
Jorquera F; León, Spain.
Simón MA; Zaragoza, Spain.
Olveira A; Madrid, Spain.
Hernández-Guerra M; Vila Real, Portugal.
Mesquita M; Porto, Portugal.
Presa J; Porto, Portugal.
Costa-Moreira P; Santa Cruz de Tenerife, Spain.
Macedo G; Santa Cruz de Tenerife, Spain.
Arenas JI; San Sebastian, Spain.
Manuel Sousa J; Sevilla, Spain.
Ampuero J; Sevilla, Spain.
Morillas RM; Barcelona, Spain.
Santos A; Coimbra, Spain.
De Carvalho A; Coimbra, Spain.
Uriz J; Navarra, Spain.
Carrión JA; Barcelona, Spain.
Luisa Gutiérrez M; Madrid, Spain.
Pérez-Fernández E; Madrid, Spain.
Fernández-Rodríguez CM; Madrid, Spain.
Pokaż więcej
Corporate Authors:
IBER-PBC leading Cooperative Group
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Feb; Vol. 53 (4), pp. 519-530. Date of Electronic Publication: 2020 Dec 12.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Liver Cirrhosis, Biliary*/drug therapy
Ursodeoxycholic Acid*/adverse effects
Chenodeoxycholic Acid/analogs & derivatives ; Cholagogues and Choleretics/adverse effects ; Humans ; Prospective Studies ; Spain
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Inhibiting P2Y12 in Macrophages Induces Endoplasmic Reticulum Stress and Promotes an Anti-Tumoral Phenotype.
Autorzy:
Pavlović N; Medical Cell Biology, Uppsala University, 75123 Uppsala, Sweden.
Kopsida M; Medical Cell Biology, Uppsala University, 75123 Uppsala, Sweden.
Gerwins P; Medical Cell Biology, Uppsala University, 75123 Uppsala, Sweden.; Radiology, Uppsala University Hospital, 75237 Uppsala, Sweden.
Heindryckx F; Medical Cell Biology, Uppsala University, 75123 Uppsala, Sweden.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2020 Oct 31; Vol. 21 (21). Date of Electronic Publication: 2020 Oct 31.
Typ publikacji:
Journal Article
MeSH Terms:
Endoplasmic Reticulum Stress/*drug effects
Liver Cirrhosis, Experimental/*prevention & control
Liver Neoplasms, Experimental/*prevention & control
Macrophages/*metabolism
Receptors, Purinergic P2Y12/*chemistry
Taurochenodeoxycholic Acid/*pharmacology
Ticagrelor/*pharmacology
Animals ; Cell Line, Tumor ; Cholagogues and Choleretics/pharmacology ; Humans ; Liver Cirrhosis, Experimental/metabolism ; Liver Cirrhosis, Experimental/pathology ; Liver Neoplasms, Experimental/metabolism ; Liver Neoplasms, Experimental/pathology ; Male ; Mice ; Mice, Inbred C57BL ; Purinergic P2Y Receptor Antagonists/pharmacology ; Receptors, Purinergic P2Y12/metabolism ; Unfolded Protein Response/drug effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of Deoxycholic Acid on Oesophageal Adenocarcinoma Invasion: Effect on Matrix Metalloproteinases.
Autorzy:
Quilty F; School of Pharmacy and Pharmaceutical Sciences, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02, Ireland.; School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8 D08, Ireland.
Byrne AM; School of Pharmacy and Pharmaceutical Sciences, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02, Ireland.; School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8 D08, Ireland.
Aird J; Department of Histopathology and Morbid Anatomy, School of Medicine, Trinity College Dublin, Dublin 2 D02, Ireland.
El Mashad S; Cork Cancer Research Centre, BioSciences Institute, University College, Cork T12 YN60, Ireland.; National Liver Institute, Menoufiya University, Shebin El Kom 32511, Egypt.
Parra-Blanco A; Department of Gastroenterology, NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham NG11 8NF, UK.
Long A; School of Medicine, Trinity Translational Medicine Institute, Trinity College Dublin, Trinity Centre for Health Sciences, St James's Hospital, Dublin 8 D08, Ireland.
Gilmer JF; School of Pharmacy and Pharmaceutical Sciences, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02, Ireland.
Medina C; School of Pharmacy and Pharmaceutical Sciences, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2 D02, Ireland.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2020 Oct 28; Vol. 21 (21). Date of Electronic Publication: 2020 Oct 28.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma/*pathology
Biomarkers, Tumor/*metabolism
Deoxycholic Acid/*pharmacology
Esophageal Neoplasms/*pathology
Esophagus/*pathology
Gene Expression Regulation, Enzymologic/*drug effects
Matrix Metalloproteinase 10/*metabolism
Adenocarcinoma/drug therapy ; Adenocarcinoma/enzymology ; Apoptosis ; Case-Control Studies ; Cell Movement ; Cell Proliferation ; Cholagogues and Choleretics/pharmacology ; Esophageal Neoplasms/drug therapy ; Esophageal Neoplasms/enzymology ; Esophageal Squamous Cell Carcinoma/drug therapy ; Esophageal Squamous Cell Carcinoma/enzymology ; Esophageal Squamous Cell Carcinoma/pathology ; Esophagus/drug effects ; Esophagus/enzymology ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Neoplasm Invasiveness ; Prognosis ; Tumor Cells, Cultured
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis.
Autorzy:
Nakano LA; Department of Gastroenterology, Division of Clinical Gastroenterology and Hepatology, Hospital das Clinicas, University of São Paulo School of Medicine, Av. Dr. Enéas Carvalho de Aguiar, 255, ICHC, 9th Floor, office 9159, São Paulo, SP 05403-000, Brazil.
Cançado ELR; Department of Gastroenterology, Division of Clinical Gastroenterology and Hepatology, Hospital das Clinicas, University of São Paulo School of Medicine, Av. Dr. Enéas Carvalho de Aguiar, 255, ICHC, 9th Floor, office 9159, São Paulo, SP 05403-000, Brazil.; Laboratory of Medical Investigation LIM 06, Institute of Tropical Medicine, University of São Paulo, São Paulo, Brazil.
Chaves CE; Division of Pharmacy of Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.
Madeira MCV; Division of Pharmacy of Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.
Katayose JT; Division of Pharmacy of Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.
Nabeshima MA; Department of Gastroenterology, Division of Clinical Gastroenterology and Hepatology, Hospital das Clinicas, University of São Paulo School of Medicine, Av. Dr. Enéas Carvalho de Aguiar, 255, ICHC, 9th Floor, office 9159, São Paulo, SP 05403-000, Brazil.
Fossaluza V; Institute of Mathematics and Statistics, University of São Paulo, São Paulo, Brazil.
Uhrigshardt GG; Institute of Mathematics and Statistics, University of São Paulo, São Paulo, Brazil.
Liting Z; Institute of Mathematics and Statistics, University of São Paulo, São Paulo, Brazil.
Pinto VB; Division of Pharmacy of Hospital das Clínicas, University of São Paulo School of Medicine, São Paulo, Brazil.
Carrilho FJ; Department of Gastroenterology, Division of Clinical Gastroenterology and Hepatology, Hospital das Clinicas, University of São Paulo School of Medicine, Av. Dr. Enéas Carvalho de Aguiar, 255, ICHC, 9th Floor, office 9159, São Paulo, SP 05403-000, Brazil.
Ono SK; Department of Gastroenterology, Division of Clinical Gastroenterology and Hepatology, Hospital das Clinicas, University of São Paulo School of Medicine, Av. Dr. Enéas Carvalho de Aguiar, 255, ICHC, 9th Floor, office 9159, São Paulo, SP 05403-000, Brazil. .
Pokaż więcej
Źródło:
BMC gastroenterology [BMC Gastroenterol] 2020 Aug 05; Vol. 20 (1), pp. 253. Date of Electronic Publication: 2020 Aug 05.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Liver Cirrhosis, Biliary*/drug therapy
Cholagogues and Choleretics/therapeutic use ; Cross-Over Studies ; Hospitals ; Humans ; Prospective Studies ; Ursodeoxycholic Acid/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 229

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies